Summary
Purpose The aim of this study is to detect apoptotic and cytotoxic/antiproliferative effects of a ligand substance and its metal derivatives. The substances were investigated by using an h-ras oncogene transformed rat embryo fibroblast cell line (5RP7). Methods The cytotoxic influences of dipyrido[3,2-a:2′,3’c]phenazine ligand, dipyrido[3,2-a:2′,3’c] phenazine-platinum(II) complex ([Pt(dppz)Cl2]) and dipyrido[3,2-a:2′,3’c] phenazine-gold(III) complex ([Au(dppz)Cl2]Cl) were determined with MTT (3[4,5-dimetiltiyazol2-yl]-2,5-difeniltetrazolyum bromid) assay on 5RP7 cells. Results Dipyrido[3,2-a:2′,3’c] phenazine, dipyrido[3,2-a:2′,3’c] phenazine-platinum(II) complex ([Pt(dppz)Cl2]) and dipyrido[3,2-a:2′,3’c] phenazine-gold(III) complexes ([Au(dppz)Cl2]Cl) caused significant increase in cytotoxicity in a dose and time dependent manner. The effects of dipyridophenazine ligand (dppz) and its metal derivatives on apoptosis were monitorized using cytotoxic dose (10 μM) DAPI fluorescent staining. It was shown that dppz and its compounds induced apoptosis. Conclusions These findings show that dpzz and its complexes can be studied as novel alternative chemotherapeutics in cancer treatment.
Similar content being viewed by others
References
Perkins E, Calvert J, Lancon JA, Parent AD, Zhang J (2003) Inhibition of H- ras as a treatment for experimental brain C6 glioma. Mol Brain Res 111:42–51
Quah SY, Tan MS, Teh YH, Stanslas J (2016) Pharmacological modulation of oncogenic Ras by natural products and their derivatives: Renewed hope in the discovery of novel anti-Ras drugs. Pharmacol Ther 162:35–57
Alama A, Tasso B, Novelli F, Sparatore F (2009) Organometallic compounds in oncology: implications of novel organotins as antitumor agents. Drug Discov Today 14:500–508
Bruijnincx PCA, Sadler PJ (2008) New trends for metal complexes with anticancer activity. Curr Opin Chem Biol 12:197–206
Pena B, David A, Pavani C, Baptista MS, Pellois J-P, Turro C, Dunbar KR (2014) Cytotoxicity studies of cyclometallated ruthenium(II) compounds: new applications for ruthenium dyes. Organometallics 33:1100–1103
Marzano C, Trevisan A, Giovagnini L, Fregona D (2002) Synthesis of a new platinum(II) complex: anticancer activity and nephrotoxicity in vitro. Toxicol in Vitro 16:413–419
Butsch K, Gust R, Klein A, Ott I, Romanski M (2010) Tuning the electronic properties of dppz-ligands and their palladium (II) complexes. Dalton Trans 39:4331–4340
Ma DL, Che CM, Yan SC (2009) Platinum(II) Complexes with Dipyridophenazine Ligands as Human Telomerase Inhibitors and Luminescent Probes for G-Quadruplex DNA. J Am Chem Soc 131:1835–1846
Szczepanik W, Kucharczyk-Klaminska M, Stefanowicz P, Staszewska A, Szewczuk Z, Skała J, Mysiak A, Jezowska-Bojczuk M (2009) DNA oxidative cleavage induced by the novel peptide derivatives of 3-(quinoxalin-6-yl)alanine in combination with Cu(II) or Fe(II) ions. Bioinorg Chem Appl 2009:906836. https://doi.org/10.1155/2009/906836
Palanichamy K, Ontko AC (2006) Synthesis, characterization, and aqueous chemistry of cytotoxic Au(III) polypyridyl complexes. Inorg Chim Acta 359:44–52
Casas JS, Castano MV, Cifuentes MC, Garcia-Monteagudo JC, Sanchez A, Sordo J, Abram U (2004) Complexes of dichloro[2-(dimethylaminomethyl)phenyl-C1, N]gold(III), [Au(damp-C1,N)Cl2], with formylferrocene thiosemicarbazones: synthesis, structure and cytotoxicity. J Inorg Biochem 98:1009–1016
Kiechle FL, Zhang X (2002) Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta 326:27–45
Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G, Liotta LA (1987) Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha- ras plus Ad2-E1a. Cancer Res 47:1523–1528
Dickeson JE, Summers LA (1970) Derivatives of 1,10-Phenanthroline-5,6-quinone. Aust J Chem 23:1023–1027
Marcon G, Carotti S, Coronnello M, Messori L, Mini E, Orioli P, Mazzei T, Cinellu MA, Minghetti G (2002) Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties. J Med Chem 45:1672–1677
Cusumano M, Di Pietro ML, Giannetto A (2006) DNA interaction of platinum(II) complexes with 1,10-phenanthroline and extended phenanthrolines. Inorg Chem 45:230–235
McConnell AA, Brown DH, Smith WE (1981) The vibrational properties of some gold(iii)-halide complexes. Spectrochim Acta Part A 37:583–585
Vellonen KS, Honkakoski P, Urtti A (2004) Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. Eur J Pharm Sci 23:181–188
Yaka E, Yüksel Eğrilmez M, Keskinoğlu P, Çavdar Z, Genç Ş, Genç K, İyilikçi L, Yener GG (2006) Alzheimer Hastalığında Beyin Omurilik Sıvısında (Bos)Biyolojik Belirteçler ve Bos’un PC12 Hücre Hattı Canlılığı Üzerine İnvitro Etkisinin Değerlendirilmesi. Turk J Geriatr 9(1):1–7
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immun Met 65:55–63
Krishan A, Dandekar PD (2005) DAPI Fluorescence in Nuclei Isolated from Tumors. J Histochem Cytochem 53(8):1033–1036
Ronconi L, Sadler PJ (2007) Using coordination chemistry to design new medicines. Coord Chem Reviews 251:1633–1648
Terenzi A, Barone G, Silvestri A, Giuliani AM, Ruggirello A, Liveri VT (2009) The interaction of native calf thymus DNA with FeIII-dipyrido[3,2-a:2′,3′-c]phenazine. J Inorg Biochem 103:1–9
Roy S, Hagen KD, Maheswari PU, Lutz M, Spek AL, Reedijk J, Wezel GP (2008) Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs. Chem Med Chem 3:1427–1434
Aguirre JD, Angeles-Boza AM, Chouai A, Turro C, Pellois JP, Dunbar KR (2009) Anticancer activity of heteroleptic diimine complexes of dirhodium: a study of intercalating properties, hydrophobicity and in cellulo activity. Dalton Trans 48:10806–10812
Carotti S, Guerri S, Mazzei T, Messori L, Mini E, Orioli P (1998) Gold(III) compounds as potential antitumor agents: cytotoxicity and DNA binding properties of some selected polyamine-gold(III) complexes. Inorg Chim Acta 281:90–94
Tekin N, Ustuner MC, Akyuz F, Ozbayer CS, Aydın O, Benkli K, Burukoglu D, Degirmenci I, Ozden H (2014) Apoptotic effects of dipyrido [3,2-a:2′,3′-c] phenazine (dppz) Au(III) complex against diethylnitrosamine/phenobarbital induced experimental hepatocarcinogenesis in rats. Mol Bio Rep 41:5109–5121
Arancibia A, Concepcion J, Daire N, Leiva G, Leiva AM, Loeb B, Del Rio R, Diaz R, Francois A, Saldivia M (2001) Electronic effects of donor and acceptor Substituents On dipyrido(3,2-A:2′,3’-C)phenazine (dpzz). J Coord Chem 54:323–336
Hussain A, Saha S, Majumdar R, Dighe RR, Chakravarty AR (2011) Photocytotoxicity and DNA photocleavage activity of La(III) and Gd(III) complexes of phenanthroline bases. Ind J Chem 50:519–530
Scharwitz MA, Ott I, Gust R, Kromm A, Sheldrick WS (2008) Synthesis, cellular uptake and structure-activity relationships for potent cytotoxic trichloridoiridium(III) polypyridyl complexes. J Inorg Biochem 102:1623–1630
Acknowledgements
This work was financed by a grant from the Scientific and Technological Research Council of Turkey (TUBITAK-SBAG-108S206). The authors are grateful to Anadolu University and Bezmialem University. We would like to thank Barlas Benkli due to contributions related to corrections of english language.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethical approval
This article does not include any studies with human participants or animals.
Rights and permissions
About this article
Cite this article
Kaplan, A., Benkli, K. & Koparal, A.T. The in vitro assessment of dipyridophenazine complexes in H-ras oncogene transformed rat embryo fibroblast 5RP7 cell line. Invest New Drugs 36, 755–762 (2018). https://doi.org/10.1007/s10637-017-0559-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-017-0559-4